US Stocks
/
Processa Pharmaceuticals, Inc. Share Price

Processa Pharmaceuticals, Inc. Share Price

NASDAQ: PCSA | Micro Cap
$1.91
+$0.11 (6.11%) Last updated on 29 Oct, 2026 | 01:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Processa Pharmaceuticals, Inc. Stock Performance

Open
$1.91
Prev. Close
$1.80
Circuit Range
N/A
Day Range
$1.91 - $1.91
Year Range
$0.11 - $8.60
Volume
133
Average Traded
$1.91

Processa Pharmaceuticals, Inc. Share Price Today

As of 29 October 2026, Processa Pharmaceuticals, Inc.'s share price is $1.91. The stock opened at $1.91, compared to its previous close of $1.80. During today's trading session, Processa Pharmaceuticals, Inc.'s share price traded between $1.91 and $1.91, with an average price of $1.91. Over the past 52 weeks, the stock has recorded a high of $8.60 and a low of $0.11. In terms of performance, Processa Pharmaceuticals, Inc.'s share price has declined by 30.29% over the last six months and is up 392.27% on a year-on-year basis.

Processa Pharmaceuticals, Inc. Share Price Chart

$1.91$1.91
L
Show Current Price
H

Processa Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.50M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.81
Revenue (TTM)
$0.00
Return On Equity (TTM)
4234.62%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
4.94%

Processa Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.44-$3.36-$3.38-$3.27
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A2.33%-0.60%3.25%

Processa Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$27.42-$11.12-$11.85-$13.56
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A59.45%-6.56%-14.43%

About Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

Processa Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.73
$1.91
+11.70%
Sep 2026
$2.06
$1.71
-18.96%
Aug 2026
$2.10
$2.11
-1.86%
Jul 2026
$1.96
$2.15
+13.46%
Jun 2026
$2.63
$1.90
-27.12%
May 2026
$2.69
$2.60
-5.11%
Apr 2026
$2.69
$2.74
+2.24%
Mar 2026
$2.17
$2.68
+20.18%
Feb 2026
$2.77
$2.23
-28.30%
Jan 2026
$2.95
$3.11
+7.99%
Dec 2025
$0.26
$2.88
+1,016.28%
Nov 2025
$0.39
$0.26
-33.51%

PCSA Share Price FAQs

What is Processa Pharmaceuticals, Inc. share price today?

chevron-up
Processa Pharmaceuticals, Inc. share price today is $1.91 as on October 29, 2026 at 1:25 am IST.

What is the 52 week high and 52 week low of Processa Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Processa Pharmaceuticals, Inc. stock is $8.60, while the 52 week low is $0.11 as of 29 Oct '26.

What is PCSA's market capitalisation today?

chevron-up
PCSA market capitalisation is $2.50M as of October 29, 2026, at 4:53 am IST.

What is PCSA's net income for the last quarter?

chevron-up
PCSA's net income for the last quarter is -3.27B USD.

What is the 5 year returns of PCSA?

chevron-up
The 5 year returns of PCSA is -98.62% as on 29 Oct '26.

What is the high & low stock price of PCSA today?

chevron-up
PCSA stock price hit a high of $1.91 and low of $1.91 as of 29 Oct '26.

Can I buy PCSA shares in India?

chevron-up
Yes. You can buy PCSA in India by opening an international trading account.